Variability and validity of polymorphism association studies in Parkinson's disease

被引:196
作者
Tan, EK [1 ]
Khajavi, M [1 ]
Thornby, JI [1 ]
Nagamitsu, S [1 ]
Jankovic, J [1 ]
Ashizawa, T [1 ]
机构
[1] Baylor Coll Med, Dept Neurol, Vet Affairs Med Ctr, Houston, TX 77030 USA
关键词
D O I
10.1212/WNL.55.4.533
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: In recent years, interest in gene-environment interactions has spurred a great number of association studies on polymorphism of different genes. Objective: To review case-control studies of genetic polymorphisms in PD, and perform meta-analysis of individual gene polymorphism. Methods: The authors searched the Medline database (PubMed) for publications (English language) from January 1966 to November 1999 for association studies in PD. The key words used were "PD" and "polymorphism." The authors supplemented the search with relevant references quoted in these published articles. Those with four or more independent studies of a specific gene polymorphism were subjected to meta-analysis, with the exception of cytochrome-P450 enzyme polymorphisms, for which meta-analyses results were already available in the literature. Results: The authors identified 84 studies on 14 genes, including dopamine receptors (DRD2 and DRD4), dopamine transporter (DAT), monoamine oxidase (MAOA and MAOB), catechol-O-methyltransferase (COMT), N-acetyltransferase 2 (NAT2), APOE, glutathione transferase (GSTT1, GSTM1, GSTP1, and GSTZ1), and mitochondrial genes (tRNA(Glu) and ND2). Four polymorphisms showed significant association with PD: slow acetylator genotypes of NAT2 (PD:control OR = 1.36), allele >188bp of the MAOB (GT)(n) polymorphism (OR = 2.58), the deletion allele of GSTT1 (OR = 1.34), and A4336G of tRNA(Glu) (OR = 3.0). No significant differences were found for the other genes. Conclusion: Significant associations with PD were found in polymorphisms of NAT2, MAOB, GSTT1, and tRNA(Glu). Although significant association does not imply a causal relationship between the presence of the polymorphisms and PD pathogenesis, their pathophysiologic significance should be studied further.
引用
收藏
页码:533 / 538
页数:6
相关论文
共 25 条
  • [1] [Anonymous], 1999, NAT GENET, V22, P1
  • [2] Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease
    Bandmann, O
    Vaughan, J
    Holmans, P
    Marsden, CD
    Wood, NW
    [J]. LANCET, 1997, 350 (9085) : 1136 - 1139
  • [3] Alpha-2 macroglobulin is genetically associated with Alzheimer disease
    Blacker, D
    Wilcox, MA
    Laird, NM
    Rodes, L
    Horvath, SM
    Go, RCP
    Perry, R
    Watson, B
    Bassett, SS
    McInnis, MG
    Albert, MS
    Hyman, BT
    Tanzi, RE
    [J]. NATURE GENETICS, 1998, 19 (04) : 357 - 360
  • [4] Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism
    Bon, MAM
    Steur, ENHJ
    de Vos, RAI
    Vermes, I
    [J]. NEUROSCIENCE LETTERS, 1999, 266 (02) : 149 - 151
  • [5] Christensen PM, 1998, PHARMACOGENETICS, V8, P473
  • [6] De Palma G, 1998, LANCET, V352, P1986
  • [7] Identification of 167 polymorphisms in 88 genes from candidate neurodegeneration pathways
    Emahazion, T
    Jobs, M
    Howell, WM
    Siegfried, M
    Wyöni, PI
    Prince, JA
    Brookes, AJ
    [J]. GENE, 1999, 238 (02) : 315 - 324
  • [8] Fleiss JL., 1973, STAT METHODS RATES P
  • [9] Association studies of genetic polymorphisms and complex disease
    Gambaro, G
    Anglani, F
    D'Angelo, A
    [J]. LANCET, 2000, 355 (9200) : 308 - 311
  • [10] ON COMBINATION OF RELATIVE RISKS
    GART, JJ
    [J]. BIOMETRICS, 1962, 18 (04) : 601 - &